Harriet W. Hamilton - Concepedia

Author

Harriet W. Hamilton

Pfizer (United States)

Also Known As

H. Hamilton, H. W. HAMILTON, H. W. Hamilton, H.W. Hamilton, Harriet W Hamilton, Harriet W. Hamilton, Tomi K. Sawyer

Publications

744

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Warde Medical Laboratory Warner University

About

Harriet W. Hamilton is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	367
2	Natural Sciences	5	5	335
3	Biochemistry	5	5	207
4	Chemical Biology	2	2	111
5	Biomolecular Engineering	1	1	62

Harriet W. Hamilton

Publications

682

Citations

H-Index

Page 1

	Year	Citations
A Highly Efficient Procedure for 3-Sulfenylation of Indole-2-carboxylates Kevin M. Schlosser, Alexei P. Krasutsky, Harriet W. Hamilton, Organic Letters Combinatorial ChemistryNatural Product SynthesisBioorganic ChemistryHighly Efficient ProcedureNatural Sciences	2004	163
PD 116,948, a highly selective A1 adenosine receptor antagonist Stephen J. Haleen, R. Steffen, Harriet W. Hamilton Life Sciences Pd 116,948Molecular PharmacologyG Protein-coupled ReceptorMedicineFunctional Selectivity	1987	88
Synthesis of 5,6-Dihydro-4-hydroxy-2- pyrones as HIV-1 Protease Inhibitors: The Profound Effect of Polarity on Antiviral Activity Susan E. Hagen, J. V. N. Vara Prasad, F Boyer, Journal of Medicinal Chemistry Altmetric Attention ScoreWarner LambertAntiviral DrugChemical BiologyPharmaceutical Chemistry	1997	62
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application Harriet W. Hamilton, Daniel F. Ortwine, Donald F. Worth, Journal of Medicinal Chemistry	1985	60
Synthesis and structure-activity relationships of pyrazolo[4,3-d]pyrimidin-7-ones as adenosine receptor antagonists Harriet W. Hamilton, Daniel F. Ortwine, Donald F. Worth, Journal of Medicinal Chemistry Combinatorial ChemistryQuantitative Structure-activity RelationshipMedicinal ChemistryBiochemistryMedicine	1987	49
4-Hydroxy-5,6-dihydropyrones. 2. Potent Non-Peptide Inhibitors of HIV Protease Bradley D. Tait, Susan E. Hagen, John M. Domagala, Journal of Medicinal Chemistry	1997	48
Ribose-modified adenosine analogs as adenosine receptor agonists Michael D. Taylor, Walter H. Moos, Harriet W. Hamilton, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryAdenosine A1Adenosine ReceptorsBiochemistry	1986	48
Correlation of adenosine receptor affinities and cardiovascular activity Harriet W. Hamilton, Marianne Taylor, R. Steffen, Life Sciences Adenosine Receptor AffinitiesCardiovascular DiseaseMedicinePhysiologyVascular Biology	1987	43
N6-Substituted adenosine receptor agonists: potential antihypertensive agents Bharat K. Trivedi, C. John Blankley, James A. Bristol, Journal of Medicinal Chemistry Molecular PharmacologyHypertensionPotential Antihypertensive AgentsMolecular PhysiologyNovel N6-benzocycloalkyladenosines	1991	35
Evaluation of Physicochemical Parameters Important to the Oral Bioavailability of Peptide-like Compounds: Implications for the Synthesis of Renin Inhibitors Harriet W. Hamilton, Bruce A. Steinbaugh, Barbra H. Stewart, Journal of Medicinal Chemistry	1995	31

Page 1